143 related articles for article (PubMed ID: 1711920)
1. Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast.
Gould VE; Koukoulis GK; Virtanen I
Cell Differ Dev; 1990 Dec; 32(3):409-16. PubMed ID: 1711920
[TBL] [Abstract][Full Text] [Related]
2. Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast.
Koukoulis GK; Howeedy AA; Korhonen M; Virtanen I; Gould VE
J Submicrosc Cytol Pathol; 1993 Apr; 25(2):285-95. PubMed ID: 7686813
[TBL] [Abstract][Full Text] [Related]
3. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.
Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE
Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules.
Koukoulis GK; Virtanen I; Korhonen M; Laitinen L; Quaranta V; Gould VE
Am J Pathol; 1991 Oct; 139(4):787-99. PubMed ID: 1928301
[TBL] [Abstract][Full Text] [Related]
5. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast.
Gould VE; Koukoulis GK; Jansson DS; Nagle RB; Franke WW; Moll R
Am J Pathol; 1990 Nov; 137(5):1143-55. PubMed ID: 1700618
[TBL] [Abstract][Full Text] [Related]
6. Alteration of stromal protein and integrin expression in breast--a marker of premalignant change?
Jones JL; Critchley DR; Walker RA
J Pathol; 1992 Aug; 167(4):399-406. PubMed ID: 1383484
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer.
Moch H; Torhorst J; Dürmüller U; Feichter GE; Sauter G; Gudat F
Pathol Res Pract; 1993 Jun; 189(5):510-4. PubMed ID: 7690952
[TBL] [Abstract][Full Text] [Related]
8. Integrins and their accessory adhesion molecules in mammary carcinomas: loss of polarization in poorly differentiated tumors.
Pignatelli M; Cardillo MR; Hanby A; Stamp GW
Hum Pathol; 1992 Oct; 23(10):1159-66. PubMed ID: 1383121
[TBL] [Abstract][Full Text] [Related]
9. Co-ordinate expression of the alpha-6 integrin laminin receptor sub-unit and laminin in breast cancer.
D'Ardenne AJ; Richman PI; Horton MA; Mcaulay AE; Jordan S
J Pathol; 1991 Nov; 165(3):213-20. PubMed ID: 1662264
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of tenascin and cellular fibronectins in diverse glomerulopathies.
Assad L; Schwartz MM; Virtanen I; Gould VE
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 63(5):307-16. PubMed ID: 7685961
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
12. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast.
Clezardin P; Frappart L; Clerget M; Pechoux C; Delmas PD
Cancer Res; 1993 Mar; 53(6):1421-30. PubMed ID: 7680285
[TBL] [Abstract][Full Text] [Related]
13. Immunohistological localization of cell adhesion proteins and integrins in the periodontium.
Steffensen B; Duong AH; Milam SB; Potempa CL; Winborn WB; Magnuson VL; Chen D; Zardeneta G; Klebe RJ
J Periodontol; 1992 Jul; 63(7):584-92. PubMed ID: 1380547
[TBL] [Abstract][Full Text] [Related]
14. Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues.
Kaczmarek J; Castellani P; Nicolo G; Spina B; Allemanni G; Zardi L
Int J Cancer; 1994 Oct; 59(1):11-6. PubMed ID: 7927891
[TBL] [Abstract][Full Text] [Related]
15. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining patterns of tenascin in invasive breast carcinomas.
Shoji T; Kamiya T; Tsubura A; Hatano T; Sakakura T; Yamamoto M; Morii S
Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):53-6. PubMed ID: 1378984
[TBL] [Abstract][Full Text] [Related]
17. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
[TBL] [Abstract][Full Text] [Related]
18. Vimentin expression in benign and malignant breast epithelium.
Heatley M; Whiteside C; Maxwell P; Toner P
J Clin Pathol; 1993 May; 46(5):441-5. PubMed ID: 7686566
[TBL] [Abstract][Full Text] [Related]
19. Correlation of alpha 2 beta 1 integrin expression with histological type and hormonal receptor status in breast carcinomas.
Lanzafame S; Emmanuele C; Torrisi A
Pathol Res Pract; 1996 Oct; 192(10):1031-8. PubMed ID: 8958553
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical identification of cell types in benign and malignant breast diseases: variations in cell markers accompany the malignant state.
Rudland PS; Leinster SJ; Winstanley J; Green B; Atkinson M; Zakhour HD
J Histochem Cytochem; 1993 Apr; 41(4):543-53. PubMed ID: 8450194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
